Class Claims Tersaro Stock Plunged After Revealing Cancer Drug’s Risks

Shareholders of biopharmaceutical company Tesaro Inc. claim in a class action that the company covered up health risks associated with a cancer drug until forced by the U.S. Food and Drug Administration to report the drug’s serious adverse effects.

Read more

Obama-Era Nutrition Guidelines Put on Ice

Rolling back Obama-era nutrition guidelines for school-lunch programs, the Trump administration moved to keep calorie-count displays largely optional until at least next year, and health initiatives by the former first lady are also on the chopping block.

Read more